Niranjana Chellappa,
Dept of Pathology, Sri Ramachandra Medical Centre & Research Institute, Chennai
Sandhya Sundaram
Dept of Pathology, Sri Ramachandra Medical Centre & Research Institute, Chennai
Lawrence D Cruze
Dept of Pathology, Sri Ramachandra Medical Centre & Research Institute, Chennai
Vishwanath Pai
Dept of Surgery, Sri Ramachandra Medical Centre & Research Institute, Chennai
Simon C Durairaj
Dept of Pathology, Sri Ramachandra Medical Centre & Research Institute, Chennai
Download PDFColorectal Carcinoma is one of the most commonly diagnosed cancers worldwide. They are known to be preceded by metaplasia and adenomas. Screening, early diagnosis and intervention have found to improve the prognosis substantially. Therefore there is a vital need to identify and stratify colonic cancers according to the degree of aggressiveness. CDX2 is a master regulator of intestinal development and oncogenesis and its expression is highly specific to the intestinal epithelium. Colon cancers without CDX2 expression are often associated with an increased likelihood of aggressive features such as advanced stage, poor differentiation, vascular invasion, BRAF mutation, and the CpG island methylator phenotype.
Keywords: Colorectal Carcinoma; CDX2; immunohistochemistry
Disclaimer: Indexing of published papers is subject to the evaluation and acceptance criteria of the respective indexing agencies. While we strive to maintain high academic and editorial standards, International Journal of Research in Science and Technology does not guarantee the indexing of any published paper. Acceptance and inclusion in indexing databases are determined by the quality, originality, and relevance of the paper, and are at the sole discretion of the indexing bodies.
